CTIC trading halted today due to the FDA ODAC recommendation board meeting panel on approval of their "NHL" cancer drug pixantrone.
Board voted 0 Yes, 9 No to the question "should pixantrone be recommended for FDA approval". Main reason was that trial was not well run thus data is inconclusive (and didn't look that good to begin with). Other reasons include safety concerns (side effects) of pix.
I think richardycc called it with this old comment:
Thus it looks like the FDA will reject FDA approval for pixantrone on April 23rd and CTIC will need more trials on that drug.
Check out the comments on the Street's Adam F's chat from the hearing itself:
http://www.thestreet.com/_yahoo/sto...-blog.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NA
Doesn't look good for CTIC.